Table 1 Characteristics of PLHIV who were screened for tuberculosis and cryptococcal meningitis while they were admitted to the medical wards at KCH, Lilongwe, Malawi, 2016–2017
Characteristic | Total N (%) | HIV diagnosis on admission | P-value* | ||
|---|---|---|---|---|---|
Old diagnosis N (%) | New diagnosis N (%) | Unknown* N (%) | |||
Gender | |||||
Female | 205 (47.8) | 164 (50.2) | 24 (32.9) | 17 (58.6) | 0.01 |
Male | 224 (52.2) | 163 (49.8) | 49 (67.1) | 12 (41.4) | |
Age (years) | |||||
14–20 | 15 (3.8) | 11 (3.6) | 4 (5.7) | 0 (0.0) | |
21–30 | 87 (21.7) | 65 (21.1) | 16 (22.9) | 6 (27.3) | |
31–40 | 163 (40.8) | 124 (40.3) | 29 (41.4) | 10 (45.4) | 0.92 |
41–50 | 85 (21.2) | 67 (21.7) | 13 (18.6) | 5 (22.7) | |
50 + | 50 (12.5) | 41 (13.3) | 8 (11.4) | 1 (4.6) | |
BMI | |||||
< 18.5 | 80 (27.7) | 64 (28.2) | 13 (27.1) | 3 (21.4) | |
18.5–24.9 | 185 (64.0) | 141 (62.1) | 33 (68.7) | 11 (78.6) | 0.79 |
25.0–29.9 | 18 (6.2) | 17 (7.5) | 1 (2.1) | 0 (0.0) | |
30 + | 3 (2.1) | 5 (2.2) | 1 (2.1) | 0 (0.0) | |
CD4 count | |||||
≤ 100 cells/mm3 | 152 (41.5) | 119 (41.9) | 20 (32.3) | 12 (63.2) | |
101–200 cells/mm3 | 69 (18.9) | 46 (16.2) | 20 (32.3) | 3 (15.8) | 0.02 |
≥ 200 cells/mm3 | 145 (39.6) | 119 (41.9) | 22 (35.4) | 4 (21.0) | |
WHO clinical stage | |||||
Stage 1 | 42 (12.5) | 30 (11.4) | 11 (19.6) | 1 (6.7) | |
Stage 2 | 11 (3.3) | 10 (3.8) | 1 (1.8) | 0 (0) | 0.08 |
Stage 3 | 215 (64.0) | 164 (62.1) | 40 (71.4) | 10 (66.7) | |
Stage 4 | 68 (20.2) | 60 (22.7) | 4 (7.2) | 4 (26.6) | |